Van Diest Capital’s Columbia Research Enhanced Value ETF REVS Stock Holding History

Van Diest Capital’s Portfolio REVS Stock Details REVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$271K	Buy	+8,608	New	+$265K	0.24%	134

Other funds holding REVS

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

FIB

First Interstate Bank Billings, Montana $1.92B AUM 19.65% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

RIS

Richmond Investment Services Mequon, Wisconsin $316M AUM 30.61% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return

PVI

Pine Valley Investments Marlton, New Jersey $2.53B AUM 36.18% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

KFP

Kerr Financial Planning Fresno, California $89.6M AUM 72.71% 1-Year Est. Return

Van Diest Capital's REVS Position: Q2 2026 in Review

Van Diest Capital opened a new position in Columbia Research Enhanced Value ETF (REVS) in Q2 2026: 8,608 shares worth $271K. The stake represents 0.24% of the portfolio and ranks #134 among its holdings.

13 funds tracked by Wall St. Rank hold REVS as of Q2 2026.

Van Diest Capital held 8,608 shares of Columbia Research Enhanced Value ETF worth $271K as of Q2 2026.
Columbia Research Enhanced Value ETF was a new Van Diest Capital position in Q2 2026.
Columbia Research Enhanced Value ETF made up 0.24% of Van Diest Capital's portfolio in Q2 2026, its #134 holding.
13 funds tracked by Wall St. Rank held Columbia Research Enhanced Value ETF as of Q2 2026.

Based on Van Diest Capital's 13F filing for Q2 2026, filed 4 Aug 2026.